5-fluorouracil
Commercial- Indications
- Oncology
Company intelligence / Profile preview
Saladax Biomedical develops and commercializes rapid blood tests to support personalized medicine through therapeutic drug monitoring. Their products are used by psychiatrists to monitor adherence and optimize dosing of antipsychotics/psychiatric medications, as well as by oncologists to guide chemotherapy dosing. The company’s MyCare product lines are available in the US and Europe. They have licensed Alzheimer’s diagnostics to Siemens Healthineers, received European approval for psychiatry tests, and won awards for individualized chemotherapy dosing research. Clinical results show improved patient outcomes via optimized medication management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saladax Biomedical.